Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Durham, NC
SEC filing record 1 source field available
Fiscal year end
31 December
Satsuma Pharmaceuticals, Inc. has filed 264 SEC EDGAR filings since 29 Dec 2016

SEC filing history

Showing 126-150 of 264 matching filings.

Per page
25
Current page
6
8-K File 001-39041

8-K

Filing date
10 Aug 2021
Reporting date
10 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39041

8-K

Filing date
16 Jun 2021
Reporting date
16 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39041

FORM 8-K

Filing date
02 Jun 2021
Reporting date
01 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39041

8-K

Filing date
11 May 2021
Reporting date
11 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-255201

424B3

Filing date
06 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-255201

EFFECT filing

Filing date
30 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
28 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39041

DEFA14A

Filing date
19 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39041

DEF 14A

Filing date
19 Apr 2021
Reporting date
01 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
14 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-255201

S-3

Filing date
13 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91126

MS AMENDMENT

Filing date
09 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Apr 2021
Reporting date
01 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91126

SCHEDULE 13D

Filing date
31 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-254737

REGISTRATION STATEMENT ON FORM S-8

Filing date
26 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-39041

10-K - 2020

Filing date
25 Mar 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
8-K File 001-39041

FORM 8-K

Filing date
25 Mar 2021
Reporting date
25 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91126

GROWTH EQUITY OPPORTUNITIES 17, LLC / SATSUMA PHARMACEUTICALS -- 13D

Filing date
15 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91126

INITIAL FILING

Filing date
15 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91126

SC 13D/A

Filing date
02 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Mar 2021
Reporting date
26 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39041

FORM 8-K

Filing date
01 Mar 2021
Reporting date
26 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91126

SC 13G/A

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91126

MS AMENDMENT

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .